Objective: To enter into EU domain grabbing a regulatory compliant pharmaceutical manufacturing unit under running condition. The option can be high-end products as well as Nutraceutical manufacturing unit
Strategy: Purchase of few Marketing Authorizations relevant to EU region. Subsequent procurement of the products through contract sales, till manufacturing unit gets in place, selling the products to marketing arm, who should have strong presence in the region, and may act as a business partner as well (JV), with or without equity share
Preference: Manufacturing unit not too old, currently running and having GMP compliance with scope of modification, having turnover between Euro 5-10 million
Area of interest: Europe and UK
Company portfolio: Manufacturing over 100 products and +150 brands, catering to domestic and international markets. The formulations include Oral Liquid, Cephalosporins (Tablets, Capsule, Sachets and Dry Syrup), Cephalosporin (Dry powder injection), Small volume parenteral (Vials and Ampoules) and Lyophilized powder in vials. A cash-rich National Stock Exchange (NSE, Mumbai-India) listed organization from India, having strong entrepreneurship skills, that has helped to spread across 50 countries worldwide with 202 registered brands- another 150 in the process. After commercializing brands in parts of Africa, America, Asia, CIS and South East Asia, the organization has branched out registering its presence in London, UK. To add up to the momentum, current search is for a meaningful JV, MA and to initiate with few Marketing authorizations in line with the business line.
|Pharma licensing||In-licensing (demand)|